Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. [electronic resource]
Producer: 20100910Description: 649-55 p. digitalISSN:- 1532-1827
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antibiotics, Antineoplastic -- therapeutic use
- Female
- Gene Expression Profiling
- Humans
- Intracellular Signaling Peptides and Proteins -- antagonists & inhibitors
- Male
- Middle Aged
- Pancreatic Neoplasms -- drug therapy
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Signal Transduction
- Sirolimus -- therapeutic use
- TOR Serine-Threonine Kinases
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.